Eupraxia Pharmaceuticals Inc.
Status: Publicly traded
Direct answer
Eupraxia Pharmaceuticals Inc. is publicly traded on TSX under the ticker EPRX.TO.
Eupraxia Pharmaceuticals Inc. is a clinical-stage biopharmaceutical firm specializing in the discovery, advancement, and commercialization of innovative technologies. Its flagship compound, EP-104IAR, is currently in a Phase II clinical trial, targeting both critical unmet medical needs and pain management for knee osteoarthritis. This promising candidate is also being developed for veterinary use, specifically for...
Can you invest in Eupraxia Pharmaceuticals Inc.?
Yes. Eupraxia Pharmaceuticals Inc. is publicly traded on TSX under the ticker EPRX.TO.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Eupraxia Pharmaceuticals Inc.
Detailed equity research is provided by MarketSnap.